Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,411 | 25,158 | 77,468 | 8,266 | 0 |
| Marketable Securities | 497,299 | 527,722 | 489,040 | 179,408 | 0 |
| Receivables | 137 | 182 | 153 | 92 | 0 |
| TOTAL | $552,080 | $563,864 | $578,610 | $194,124 | $0 |
| Non-Current Assets | |||||
| PPE Net | 63 | 84 | 77 | 69 | N/A |
| Other Non-Current Assets | 328 | 382 | 421 | 5,108 | 0 |
| TOTAL | $391 | $466 | $498 | $5,177 | $N/A |
| Total Assets | $552,471 | $564,330 | $579,108 | $199,301 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,076 | 4,491 | 4,658 | 3,242 | 0 |
| Accrued Expenses | 11,329 | 7,125 | 5,106 | 10,443 | 0 |
| Other current liabilities | N/A | N/A | N/A | 352 | 0 |
| TOTAL | $15,630 | $11,853 | $9,984 | $14,254 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 71 | 118 | 184 | 308,147 | 0 |
| TOTAL | $71 | $118 | $184 | $308,147 | $N/A |
| Total Liabilities | $15,701 | $11,971 | $10,168 | $322,401 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,630 | 67,077 | 66,640 | N/A | N/A |
| Common Shares | 7 | 7 | 7 | N/A | 0 |
| Retained earnings | -186,183 | -165,778 | -146,874 | -129,942 | 0 |
| TOTAL | $536,770 | $552,359 | $568,940 | $-123,100 | $0 |
| Total Liabilities And Equity | $552,471 | $564,330 | $579,108 | $199,301 | $0 |